Jacobs Levy Equity Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-29,735
| Closed | -$1.33M | – | 983 |
|
|
2021
Q3 | $1.33M | Buy |
29,735
+7,682
| +35% | +$344K | 0.01% | 691 |
|
|
2021
Q2 | $891K | Sell |
22,053
-11,710
| -35% | -$473K | 0.01% | 760 |
|
|
2021
Q1 | $1.8M | Buy |
33,763
+18,982
| +128% | +$1.01M | 0.01% | 620 |
|
|
2020
Q4 | $591K | Buy |
+14,781
| New | +$591K | 0.01% | 827 |
|
|
2020
Q2 | – | Sell |
-4,377
| Closed | -$217K | – | 1044 |
|
|
2020
Q1 | $217K | Sell |
4,377
-2,853
| -39% | -$141K | ﹤0.01% | 869 |
|
|
2019
Q4 | $555K | Buy |
+7,230
| New | +$555K | 0.01% | 772 |
|
|
2019
Q2 | – | Sell |
-4,799
| Closed | -$254K | – | 952 |
|
|
2019
Q1 | $254K | Sell |
4,799
-1,285
| -21% | -$68K | ﹤0.01% | 861 |
|
|
2018
Q4 | $286K | Buy |
6,084
+145
| +2% | +$6.82K | 0.01% | 816 |
|
|
2018
Q3 | $523K | Buy |
5,939
+1,705
| +40% | +$150K | 0.01% | 767 |
|
|
2018
Q2 | $440K | Sell |
4,234
-969
| -19% | -$101K | 0.01% | 824 |
|
|
2018
Q1 | $416K | Buy |
5,203
+1,507
| +41% | +$120K | 0.01% | 806 |
|
|
2017
Q4 | $503K | Buy |
3,696
+1,193
| +48% | +$162K | 0.01% | 752 |
|
|
2017
Q3 | $405K | Sell |
2,503
-705
| -22% | -$114K | 0.01% | 736 |
|
|
2017
Q2 | $481K | Buy |
+3,208
| New | +$481K | 0.01% | 706 |
|